Status:
COMPLETED
Feasibility Study of the Adult Congenital Heart Disease-Coping and Resilience (ACHD-CARE) Trial
Lead Sponsor:
University Health Network, Toronto
Conditions:
Heart Defects, Congenital
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The psychosocial development of adults with congenital heart disease (CHD) can be challenged by many issues including family overprotection, impaired peer relationships, delayed progression into indep...
Eligibility Criteria
Inclusion
- Documented congenital heart disease (CHD), as confirmed by echocardiogram, cardiac catheterization, or previous surgery
- Age greater than or equal to 18 years
- English-language proficiency sufficient to read and complete the consent form and questionnaires and participate in an English-language group
- No planned surgery during patient's participation in the study
- Clinically-elevated score (i.e \>=8) on the Hospital Anxiety and Depression Scale depression (HADS-D) or anxiety (HADS-A) subscale
Exclusion
- Current psychotherapy or pharmacotherapy
- Significant cognitive impairment, psychosis, or personality disorder as documented in medical chart
- Report of suicidal intent during screening
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT01881893
Start Date
June 1 2013
End Date
December 1 2015
Last Update
December 24 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toronto Congenital Cardiac Clinic for Adults, Peter Munk Cardiac Centre, Toronto General Hospital
Toronto, Ontario, Canada, M5G 2N2